3186 results for «7929»
3186 results
Early real-world experience with Tendyne™ TMVR
18 May 2021 – From EuroPCR 2021
Watch this session presented by Stephan von Bardeleben in order to learn about real-world Tendyne results from TENDER EU, the largest reported commercial cohort, to hear expert feedback on the safety and effectiveness of Tendyne TMVI in real-life setting, and to discover how one heart team integrates Tendyne...
New 2021 ESC heart failure and valvular heart diseases guidelines : impact on secondary mitral regurgitation management
21 Nov 2021 – From PCR London Valves 2021
Join Ralph Stephan Von Bardeleben and Marco Metra if you want to learn about the new ESC 2021 guidelines in heart failure management and the key interconnections between the heart failure and the valvular heart diseases guidelines, as well as to understand how this will improve...
Diagnosis and classification of tricuspid regurgitation
11 Mar 2023 – From PCR Imaging Valves Madrid 2023
Watch this session to learn more about the anatomy of the tricuspid valve and its challenges, to know when and how to treat tricuspid regurgitation, and to discover all about the latest classification regarding this condition.
EuroPCR 2021 Hotlines / Late-Breaking Trials: CLASP, CHOICE-MI, CHOICE-MI MAC, TENDER, and Global EXPAND
26 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in mitral valve replacement & repair:
- 2-year outcomes for transcatheter mitral repair from the CLASP study
- The choice of optimal transcatheter treatment for mitral insufficiency registry
- Outcomes of patients treated for mitral annulus calcification
- TENDER - TENDyne European expeRience registry: Early outcome
- Safety...
Looking into the treatment of TR with the Edwards portfolio
18 May 2021 – From EuroPCR 2021
Watch this session presented by Georg Nickenig, Wolfgang Rottbauer and Ralph von Bardeleben in order to understand the challenges and needs regarding tricuspid valve disease treatment, to learn about the Edwards portfolio for transcatheter treatment of TR, and to discuss patient outcomes with the various treatment options Edwards offers to physicians and...
Transcatheter mitral valve replacement: patient selection and hemodynamic stability
22 Nov 2021 – From PCR London Valves
Watch this session broadcast at PCR London Valves 2021 to find out more about TMVR as a novel treatment option for patients with mitral disease, to learn how to identify the right candidate for TMVR, and to understand how to best medically manage patients peri-procedurally.
A new focus on mitral and tricuspid valve disease
18 May 2022 – From EuroPCR 2022
Find out more about the need for transcatheter replacement in the atrioventricular valves and the Intrepid programme, the potential of transvenous transseptal versus transapical access to the mitral valve, and the future of transvenous tricuspid valve replacement in this EuroPCR 2022 session.
Tricuspid valve intervention - Get it right!
29 Nov 2022 – From PCR London Valves 2022
Watch this session if you want to learn tips and tricks that influence procedural strategy through a real-life case as well as anatomical factors that contribute to tricuspid valve complexity and choice of treatment, followed by the latest clinical data.
Use of 4D ICE in tricuspid and mitral valve interventions
16 May 2023 – From EuroPCR 2023
Watch this session to know the challenges of TV imaging, to get an overview on 4D ICE technology, and to study both a transcatheter tricuspid valve procedure and a transcatheter mitral valve procedure through different case presentations, that will then be discussed.
Innovations in TMVR and Intrepid trial updates
18 May 2023 – From EuroPCR 2023
This session explores the innovations in Transcatheter Mitral Valve replacement, with a special focus on the updates from the INTREPID and APOLLO EU trial, as well as patient benefits through case studies.
How to deal with residual or recurrent mitral regurgitation after failed surgical or transcatheter repair
28 Nov 2022 – From PCR London Valves 2022
Consul this session to learn more about the available treatment options after failed mitral surgical or transcatheter procedures, the factors that increase the likelihood of residual/recurrent mitral regurgitation, and more!
Innovations in TMVR and Intrepid trial updates
29 Nov 2022 – From PCR London Valves 2022
Watch this session if you want to gain insights on the APOLLO TMVR trial, the Intrepid trial and to hear about future innovations in mitral replacement.
Is only fixing functional mitral regurgitation in heart failure patients enough?
20 Nov 2023 – From PCR London Valves 2023
This session offers insights into combo therapy involving Carillon for patients with functional mitral regurgitation. It covers details of the EMPOWER trial, a double-blinded, sham-controlled study, and explores the potential benefits of early treatment for patients with functional mitral regurgitation.
Expert roundtable: 4D ICE in tricuspid interventions
20 Nov 2023 – From PCR London Valves 2023
Join this session if you want to get familiar with the 4D ICE technology and the key elements of image guidance for tricuspid interventions, understand how 4D ICE can assist in specific procedural steps during challenging tricuspid interventions, and engage in an interactive discussion with experts...
Mastering structural heart intervention with innovations in imaging
25 Nov 2024 – From PCR London Valves 2024
Explore the future of transcatheter mitral and tricuspid therapies in this innovative session. Learn how advanced imaging techniques like CT/fluoro fusion and 4D intracardiac echocardiography are revolutionizing complex procedures, enhancing both safety and outcomes. Hear from experienced operators as they share their insights on the evolving...
Shaping the treatment of mitral regurgitation with the Intrepid transcatheter mitral valve replacement (TMVR) system
17 Nov 2025 – From PCR London Valves 2025
This session presents an in-depth examination of the Intrepid transcatheter mitral valve replacement (TMVR) system, focusing on its role in treating mitral regurgitation. It covers the system's design features, ongoing clinical research, and long-term durability, complemented by detailed analyses of transapical 5-year outcomes and current trial...
Transcatheter mitral valve replacement and repair: why do we need both
18 May 2021 – From EuroPCR 2021
Watch this session presented by Michael Borger, Nicolas Dumonteil, Paolo Denti, Lenard Conradi, Hendrik Treed and Ralph von Bardeleben in order to learn about the expanded treatment options and latest innovations in transcatheter mitral valve therapies, and to tailor your treatment options to optimise patient outcomes with...
EuroPCR 2021 Hotlines / Late-Breaking Trials: TRILUMINATE, CLASP TR, bRIGHT, TRISCEND, TriBAND, and more!
21 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in TRICUSPID:
- Percutaneous E2E repair for TR: 2-Year outcomes from the TRILUMINATE trial
- Transcatheter tricuspid valve repair: CLASP TR feasibility study 6-month results
- Clinical Response to Transcatheter treatment of tricuspid regurgitation: International TriValve registry
- Baseline characteristics and procedure outcomes from TriClip bRIGHT...
Complex tricuspid interventions
20 Nov 2023 – From PCR London Valves 2023
Consult this session to discover a selection of abstracts regarding tricuspid valve procedures: explore the complexities of long-term right heart remodeling after transcatheter tricuspid annuloplasty, witness the journey from pre-clinical studies to the first-in-man experience with MonarQ tricuspid valve replacement, delve into Tripair, an innovative transcatheter spacer...
Therapeutic choices for TTVIV-TTVIR interventions
21 May 2025 – From EuroPCR 2025
Explore therapeutic choices for transcatheter tricuspid valve-in-valve and valve-in-ring interventions. Case studies cover annular ring expansion, pacing-related infection, jugular vein access valve replacement, Ebstein anomaly, and double valve-in-valve procedures in right heart disease.
